4.10 -0.10(-2.38%)06/28/2024
Zentalis Pharmaceuticals LLC (ZNTL)
Zentalis Pharmaceuticals LLC (ZNTL)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
Headline | Time (ET) | Source |
---|---|---|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL | 06/26 14:30 | accesswire.com |
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold | 06/19 11:25 | zacks.com |
Investigation Into Zentalis Pharmaceuticals, Inc. (ZNTL) Announced byHolzer & Holzer, LLC | 06/18 11:58 | globenewswire.com |
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? | 06/18 08:44 | benzinga.com |
US FDA puts partial clinical hold on Zentalis' cancer drug studies; shares drop | 06/18 07:57 | reuters.com |
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program | 06/18 07:00 | globenewswire.com |
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 06/03 18:00 | globenewswire.com |
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | 05/30 07:00 | globenewswire.com |